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EDITORIAL
Should  we  forget  about  rectosigmoidoscopy  for the
diagnosis of  advanced  colorectal  neoplasia?,
¿Debemos  olvidar  la  rectosigmoidoscopia  para  el  diagnóstico  de  neoplasiaA
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There  is  a  rising  trend  in  colorectal  cancer  worldwide  and
despite  the  advances  in  medicine  and  the  fact  that  the
important  risk  factors  of  age  above  50  years,  male  sex,  a
family  history  of  the  disease,  smoking,  obesity,  and  diabetes
mellitus  are  recognized,  it  has  not  been  possible  to  deter-
mine  a  factor  in  the  general  population  that  can  identify
with  absolute  certainty  the  population  at  risk  for  developing
this  neoplasia.1
In  the  year  2002  in  Mexico,  a  total  of  108,064  new  cases
of  cancer  with  histopathologic  diagnoses2 were  registered.
Of  that  total,  3,791  (3.5%)  cases  corresponded  to  colorec-
tal  cancer,  speciﬁcally  2.3%  to  cancer  of  the  colon  and  1.2%
to  cancer  of  the  rectum,  situating  colorectal  cancer  among
the  ﬁrst  10  causes  of  morbidity  due  to  malignant  neoplasias.
In  2006,3 4,550  new  cases  (4.19%)  were  reported,  2.80%  of
which  corresponded  to  cancer  of  the  colon  and  1.39%  to  can-
cer  of  the  rectum,  showing  that  there  is  also  an  increasing
trend  of  this  neoplasia  in  our  country.
The  majority  of  cases  of  colorectal  cancer  (CRC)  derive
from  adenomatous  polyps  and  new  cases  can  be  prevented
and/or  reduced  through  the  detection  and  removal  of  those
polyps  through  colonoscopy.  Survival  can  also  increase  if  CRC
is  diagnosed  in  the  early  stages  of  the  disease.  However,
not  all  adenomas  present  with  the  same  risk  for  transfor-
ming  into  cancer.  Two  risk  groups  are  currently  distinguished
based  on  their  transformation  probability,  and  they  are
classiﬁed  as  low-risk  and  high-risk  adenomas.  The  low-risk
category  is  deﬁned  as  1  or  2  adenomas  smaller  than  10  mm.
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han  10  mm  or  there  are  3  or  more  polyps,  when  there  is
 villous  component,  or  there  is  the  presence  of  high  grade
ysplasia.
The  same  associated  factors  have  been  described  for  both
RC  and  advanced  neoplasia  (AN),  given  that  the  precise
actors  related  to  the  latter  are  not  known.  The  study  by
arra-Pérez  et  al.4 evaluated  the  factors  associated  with
N  and  proximal  AN  (PAN)  in  colorectal  cancer  in  a  Latin
merican  population.  They  conducted  an  observational,
ross-sectional  analysis  that  included  846  patients.  AN  was
etected  in  108  of  the  patients  and  PAN  in  55.  The  most
triking  fact  for  the  authors  was  that  of  those  55  patients,
2  had  no  neoplasia  in  the  distal  colon.  They  concluded  that
he  factors  related  to  AN  were  an  age  of  50  years  or  older
nd  male  sex,  and  the  factors  related  to  PAN  were  an  age  of
0  years  or  older,  the  presence  of  advanced  distal  neopla-
ia,  or  the  presence  of  ≥  3  non-advanced  distal  neoplasias,
ncreasing  the  risk  almost  2.5-fold.  Another  conclusion  of  the
tudy  was  that  75%  of  the  PANs  remain  undiagnosed  if  com-
lete  colonoscopy  is  not  performed,  having  a  direct  impact
n  the  morbidity  and  mortality  of  CRC.  In  their  study,  they
ere  not  able  to  identify  additional  risk  factors  for  detec-
ing  AN,  but  they  were  able  to  determine  that  distal  AN  was
n  important  risk  factor  for  the  presence  of  PAN,  concurring
ith  that  reported  in  the  literature.
As  the  authors  state  in  their  study,  the  most  impor-
ant  aim  in  the  detection  of  AN  is  to  reduce  CRC  mortality
nd  the  method  of  choice  should  be  complete  colonoscopy,
ith  the  quality  criteria  previously  described.5 The  current
ndoscopic  screening  methods  for  CRC  detection  are  sigmoi-
oscopy  and  colonoscopy.  The  observation  has  been  made
hat  there  are  increasingly  fewer  sigmoidoscopies6 and  more
olonoscopies  being  carried  out  due  to  various  factors.  How-
ver,  this  is  not  a  generalized  practice  and  sigmoidoscopy
ontinues  to  be  performed  in  many  places,  but,  as  the  study
oints  out,  in  the  absence  of  complete  colonoscopy,  6  to
5%  of  cases  of  PAN  will  not  be  diagnosed.7--9 The  recent
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ncrease  in  diagnoses  of  serrated  sessile  adenomatous  polyps
s  noteworthy.10 They  are  more  frequently  located  in  the
roximal  colon  and  the  best  method  for  diagnosing  them
s  complete  colonoscopy,  adding  another  reason  for  discon-
inuing  ﬂexible  sigmoidoscopy,  especially  in  symptomatic
atients  or  in  those  being  screened.
The  primary  aim  of  this  study  was  to  determine  the  risk
actors  for  AN  and  PAN.  Unfortunately,  no  factor  has  yet  been
dentiﬁed  that  can  have  a  direct  impact  on  the  quality  of
are  for  this  population.  We  depend  on  the  factors  men-
ioned  above,  together  with  our  clinical  judgment,  to  make
he  decision  to  perform  a  screening  procedure  for  CRC.  It
s  a  well  accepted  fact  that  the  most  important  goal  in  the
etection  of  AN  is  to  reduce  the  mortality  caused  by  CRC.
herefore  it  is  necessary  to  continue  to  conduct  studies  that
istinguish  the  risk  factors  in  the  population  at  average  risk
or  CRC,  as  well  as  to  deﬁne  the  current  role  of  sigmoi-
oscopy  as  a  screening  method  for  CRC,  given  the  increasing
umber  of  proximal  colorectal  neoplasias  reported.  For  now,
aking  into  account  the  present  conditions  in  Mexico,  which
re  similar  to  those  in  all  Latin  America,  it  is  very  likely
hat  sigmoidoscopy  will  continue  to  be  a  useful  and  utilized
ethod  for  CRC  screening,  a  circumstance  that  is  still  sup-
orted  by  results  reported  in  the  national  and  international
iterature.
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